EquityZen Growth Technology Fund LLC - Series 1072
Raised
$492K
Investors
30
Min Invest
$10,006
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1072 is a Delaware-based pooled investment vehicle filed November 2021, raising $492K from 30 investors ($10K minimum) under Rule 506(b) and 3(c)(1) exemptions. Managed by EquityZen Advisors with Assure Fund Management II as director, this is one of approximately 1,889 series vehicles in the EquityZen pre-IPO secondary marketplace platform.
This pre-IPO fund follows the typical EquityZen SPV structure: a 506(b) private placement with 3(c)(1) exemption limiting investors to 100 beneficial owners, offering retail-accessible $10K minimums. The $16.4K average commitment and 30-investor count align with the platform's model of pooling small checks for access to late-stage private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
